Literature DB >> 18474655

Molecular variations in Klebsiella pneumoniae and Escherichia coli FimH affect function and pathogenesis in the urinary tract.

David A Rosen1, Jerome S Pinkner, Jennifer N Walker, Jennifer Stine Elam, Jennifer M Jones, Scott J Hultgren.   

Abstract

Type 1 pili mediate binding, invasion, and biofilm formation of uropathogenic Escherichia coli (UPEC) in the host urothelium during urinary tract infection (UTI) via the adhesin FimH. In this study, we characterized the molecular basis of functional differences between FimH of the UPEC isolate UTI89 and the Klebsiella pneumoniae cystitis isolate TOP52. Type 1 pili characteristically mediate mannose-sensitive hemagglutination of guinea pig erythrocytes. Although the adhesin domain of K. pneumoniae TOP52 FimH (FimH(52)) is highly homologous to that of E. coli, with an identical mannose binding pocket and surrounding hydrophobic ridge, it lacks the ability to agglutinate guinea pig erythrocytes. In addition, FimH-dependent biofilm formation in K. pneumoniae is inhibited by heptyl mannose, but not methyl mannose, suggesting the need for contacts outside of the mannose binding pocket. The binding specificity differences observed for FimH(52) resulted in significant functional differences seen in the pathogenesis of K. pneumoniae UTI compared to E. coli UTI. Infections in a murine model of UTI demonstrated that although the K. pneumoniae strain TOP52 required FimH(52) for invasion and IBC formation in the bladder, FimH(52) was not essential for early colonization. This work reveals that a limited amount of sequence variation between the FimH of E. coli and K. pneumoniae results in significant differences in function and ability to colonize the urinary tract.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18474655      PMCID: PMC2446687          DOI: 10.1128/IAI.00340-08

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  61 in total

1.  Ecology, physiology, and genetics of fimbriae and pili.

Authors:  J C Ottow
Journal:  Annu Rev Microbiol       Date:  1975       Impact factor: 15.500

Review 2.  Bacterial adherence--a pathogenetic mechanism in urinary tract infections caused by Escherichia coli.

Authors:  C Svanborg Edén; L Hagberg; L A Hanson; S Hull; R Hull; U Jodal; H Leffler; H Lomberg; E Straube
Journal:  Prog Allergy       Date:  1983

3.  Role of type 1 pili and effects of phase variation on lower urinary tract infections produced by Escherichia coli.

Authors:  S J Hultgren; T N Porter; A J Schaeffer; J L Duncan
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

4.  Construction and expression of recombinant plasmids encoding type 1 or D-mannose-resistant pili from a urinary tract infection Escherichia coli isolate.

Authors:  R A Hull; R E Gill; P Hsu; B H Minshew; S Falkow
Journal:  Infect Immun       Date:  1981-09       Impact factor: 3.441

5.  Carbohydrate-binding sites of the mannose-specific fimbrial lectins of enterobacteria.

Authors:  N Firon; I Ofek; N Sharon
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

6.  Utilization of an intracellular bacterial community pathway in Klebsiella pneumoniae urinary tract infection and the effects of FimK on type 1 pilus expression.

Authors:  David A Rosen; Jerome S Pinkner; Jennifer M Jones; Jennifer N Walker; Steven Clegg; Scott J Hultgren
Journal:  Infect Immun       Date:  2008-04-14       Impact factor: 3.441

7.  Carbohydrate specificity of the surface lectins of Escherichia coli, Klebsiella pneumoniae, and Salmonella typhimurium.

Authors:  N Firon; I Ofek; N Sharon
Journal:  Carbohydr Res       Date:  1983-08-16       Impact factor: 2.104

8.  Effect of piliation on Klebsiella pneumoniae infection in rat bladders.

Authors:  R C Fader; C P Davis
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

9.  Hemagglutination by purified type I Escherichia coli pili.

Authors:  I E Salit; E C Gotschlich
Journal:  J Exp Med       Date:  1977-11-01       Impact factor: 14.307

10.  Lambda Red-mediated recombinogenic engineering of enterohemorrhagic and enteropathogenic E. coli.

Authors:  Kenan C Murphy; Kenneth G Campellone
Journal:  BMC Mol Biol       Date:  2003-12-13       Impact factor: 2.946

View more
  35 in total

Review 1.  Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.

Authors:  Thomas J Hannan; Makrina Totsika; Kylie J Mansfield; Kate H Moore; Mark A Schembri; Scott J Hultgren
Journal:  FEMS Microbiol Rev       Date:  2012-05       Impact factor: 16.408

2.  Structure-based drug design and optimization of mannoside bacterial FimH antagonists.

Authors:  Zhenfu Han; Jerome S Pinkner; Bradley Ford; Robert Obermann; William Nolan; Scott A Wildman; Doug Hobbs; Tom Ellenberger; Corinne K Cusumano; Scott J Hultgren; James W Janetka
Journal:  J Med Chem       Date:  2010-06-24       Impact factor: 7.446

Review 3.  Invasion of Host Cells and Tissues by Uropathogenic Bacteria.

Authors:  Adam J Lewis; Amanda C Richards; Matthew A Mulvey
Journal:  Microbiol Spectr       Date:  2016-12

Review 4.  Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era.

Authors:  Maria Kostakioti; Maria Hadjifrangiskou; Scott J Hultgren
Journal:  Cold Spring Harb Perspect Med       Date:  2013-04-01       Impact factor: 6.915

5.  Combinatorial small-molecule therapy prevents uropathogenic Escherichia coli catheter-associated urinary tract infections in mice.

Authors:  Pascale S Guiton; Corinne K Cusumano; Kimberly A Kline; Karen W Dodson; Zhenfu Han; James W Janetka; Jeffrey P Henderson; Michael G Caparon; Scott J Hultgren
Journal:  Antimicrob Agents Chemother       Date:  2012-06-25       Impact factor: 5.191

6.  Cystoman® and calculi: a good alternative to standard therapies in preventing stone recurrence.

Authors:  S Proietti; A Giannantoni; L G Luciani; G Sortino; P Graziotti; G Giusti
Journal:  Urolithiasis       Date:  2014-06-28       Impact factor: 3.436

7.  BamB and outer membrane biogenesis - The Achilles' heel for targeting Klebsiella infections?

Authors:  Anne Marie Krachler
Journal:  Virulence       Date:  2016-04-29       Impact factor: 5.882

Review 8.  Urinary tract infections: epidemiology, mechanisms of infection and treatment options.

Authors:  Ana L Flores-Mireles; Jennifer N Walker; Michael Caparon; Scott J Hultgren
Journal:  Nat Rev Microbiol       Date:  2015-04-08       Impact factor: 60.633

Review 9.  Pathophysiology, Treatment, and Prevention of Catheter-Associated Urinary Tract Infection.

Authors:  Ana Flores-Mireles; Teri N Hreha; David A Hunstad
Journal:  Top Spinal Cord Inj Rehabil       Date:  2019

Review 10.  Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.

Authors:  Valerie P O'Brien; Thomas J Hannan; Hailyn V Nielsen; Scott J Hultgren
Journal:  Microbiol Spectr       Date:  2016-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.